EHMT2 and prostate carcinoma: Interestingly, a previous study reported that EHMT2 can methylate lysine 114 of LSD1, leading to its recognition and interaction with the chromatin-remodeling protein CHD1 to activate gene transcription in prostate cancer cells (19).